Edition:
United States

Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

11.86USD
22 Jul 2016
Change (% chg)

$-0.02 (-0.17%)
Prev Close
$11.88
Open
$11.91
Day's High
$12.01
Day's Low
$11.73
Volume
16,292
Avg. Vol
48,506
52-wk High
$25.00
52-wk Low
$9.80

CNCE.OQ

Chart for CNCE.OQ

About

Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others segment. It has clinical candidates under... (more)

Overall

Beta: --
Market Cap(Mil.): $263.49
Shares Outstanding(Mil.): 22.22
Dividend: --
Yield (%): --

Financials

  CNCE.OQ Industry Sector
P/E (TTM): 14.63 39.80 37.05
EPS (TTM): 0.81 -- --
ROI: 16.66 -5.86 14.35
ROE: 18.23 -4.70 15.56

BRIEF-Concert Pharmaceuticals reports Q1 loss per share $0.63

* Concert pharmaceuticals reports first quarter 2016 financial results

May 05 2016

BRIEF-Concert Pharmaceuticals announces positive data from phase 1 of CTP-656

* Announces Positive Data From Multiple Dose Phase 1 Clinical Trial Of Ctp-656, lead candidate for the treatment of cystic fibrosis

Apr 28 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Ford Investor Services, Inc.
$12.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.